BiotechTube
Home/Relay Therapeutics/Sanjiv K. Patel
SK

Sanjiv K. Patel

President & Chief Executive Officer

Relay Therapeutics

Therapeutic Areas

OncologyGenetic Disease

Relay Therapeutics Pipeline

DrugIndicationPhase
RLY-4008FGFR2-altered solid tumors (e.g., cholangiocarcinoma)Phase 1/2
RLY-2608Advanced breast cancer and other solid tumors with PIK3CA mutationsPhase 1
RLY-5836Undisclosed precision oncology targetPreclinical
GDC-1971 (formerly RLY-1971)UndisclosedPhase 1

Leadership Team at Relay Therapeutics

DB
Don Bergstrom
Former President of R&D
TC
Tom Catinazzo
Chief Financial Officer
View full Relay Therapeutics profile